Skip to content

Heterotaxy Syndrome and Intestinal Rotation Abnormalities - A Prospective Study

Heterotaxy Syndrome and Intestinal Rotation Abnormalities - A Prospective Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01591928
Enrollment
40
Registered
2012-05-04
Start date
2012-03-31
Completion date
2016-12-31
Last updated
2018-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heterotaxy Syndrome

Keywords

Pediatrics, Congenital heart disease, Heterotaxy syndrome, Intestinal malrotation

Brief summary

Infants with heterotaxy syndrome (HS) are born with an abnormal arrangement of organs along the right-left body axis. Abnormalities of intestinal rotation and fixation are commonly associated with HS. Malrotation is the most worrisome intestinal rotation abnormality (IRA). Advances in cardiac surgery have improved HS mortality such that there is increasing attention to IRA and their management. The objective of this research project is to prospectively observe a cohort of infants with HS and IRA and evaluate their long term outcomes. Specifically, the investigators would like to determine what is the natural history of asymptomatic IRA in patients with HS and what is the morbidity and mortality secondary to an elective Ladd procedure for asymptomatic IRA in a population with HS? The investigators plan a prospective, multi-center, observational study to follow this complicated group of patients. This will be a web-based database collected from major cardiac tertiary care centers in both Canada and the United States. Patients with HS will be recruited by their primary site and clinical data will be collected by their primary site prospectively throughout childhood until they are at least five years of age. This patient population will be followed by their own clinical care givers; this is not an interventional study. No additional clinic visits will be required and the patients will not have to be contacted. Patient medical records will be accessed by a member of the study team at the primary site at least once per year or more frequently if interventions are required or complications develop.

Interventions

None listed

Sponsors

University of Alberta
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Days to 6 Months
Healthy volunteers
No

Inclusion criteria

* All infants less than or equal to six months of age with a new diagnosis of heterotaxy syndrome

Design outcomes

Primary

MeasureTime frameDescription
Midgut volvulusFirst year of lifeSurgical intervention

Secondary

MeasureTime frame
Morbidity secondary to a prophylactic Ladd procedurePost Ladd procedure
Mortality secondary to a prophylactic Ladd procedureWithin one month of Ladd procedure

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026